Related Experiment Videos
Oxidative stress and lung diseases.
R Maselli1, R D Grembiale, G Pelaia
1Dipartimento di Medicina Sperimentale e Clinica G. Salvatore, Università degli Studi Magna Graecia di Catanzaro, Policlinico Mater Domini, Via Tommaso Campanella, 88100 Catanzaro, Italy. rmaselli@unicz.it
Summary
Oxidative stress in lung diseases activates mitogen-activated protein kinases (MAPK). Corticosteroids effectively inhibit this MAPK activation, offering potential for new antioxidant treatments targeting respiratory disorders.
Area of Science:
- Pulmonary medicine
- Cellular signaling
- Molecular biology
Background:
- Lung diseases often involve an oxidant/antioxidant imbalance, leading to cellular damage.
- Oxidative stress triggers intracellular signaling pathways regulating transcription factors like NF-kappa B and AP-1.
- Mitogen-activated protein kinases (MAPK) are crucial in pulmonary endothelial and airway epithelial cells.
Purpose of the Study:
- To investigate the role of MAPK in oxidative stress-induced lung cell damage.
- To determine the effect of corticosteroids on MAPK activation in the context of oxidative stress.
- To explore potential new therapeutic strategies for respiratory disorders.
Main Methods:
- Exposing pulmonary endothelial and airway epithelial cell lines to oxidant agents.
- Measuring MAPK activation in response to oxidative stress.
- Assessing the inhibitory effect of corticosteroids on MAPK activation.
Main Results:
- Oxidative stress significantly activates MAPK in lung cells.
- Corticosteroids effectively inhibit this oxidative stress-induced MAPK activation.
- MAPK plays a key role in the cellular response to oxidative and proinflammatory stimuli.
Conclusions:
- MAPK activation is a significant molecular event in oxidative stress-related lung conditions.
- Corticosteroids demonstrate therapeutic potential by inhibiting MAPK activation.
- Findings suggest novel antioxidant treatments targeting MAPK modulation for respiratory diseases.